Gerrit Anne van Es
Overview
Explore the profile of Gerrit Anne van Es including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
787
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Costa F, Brugaletta S, Pernigotti A, Flores-Ulmanzor E, Ortega-Paz L, Cequier A, et al.
Circ Cardiovasc Interv
. 2019 Aug;
12(9):e007705.
PMID: 31451013
Background: Drug-eluting stents (DES) showed improved efficacy and safety compared with bare-metal stents (BMS), and international guidelines recommend their use as first line treatment. Yet, BMS are still widely used...
2.
Vranckx P, Valgimigli M, Juni P, Hamm C, Steg P, Heg D, et al.
Lancet
. 2018 Sep;
392(10151):940-949.
PMID: 30166073
Background: We hypothesised that ticagrelor, in combination with aspirin for 1 month, followed by ticagrelor alone, improves outcomes after percutaneous coronary intervention compared with standard antiplatelet regimens. Methods: GLOBAL LEADERS...
3.
Yamaji K, Brugaletta S, Sabate M, Iniguez A, Jensen L, Cequier A, et al.
JACC Cardiovasc Interv
. 2017 Sep;
10(18):1867-1877.
PMID: 28935079
Objectives: This study sought to investigate the effect of post-dilatation on angiographic and intracoronary imaging parameters in the setting of primary percutaneous coronary intervention comparing the everolimus-eluting bioresorbable scaffold (BRS)...
4.
Vranckx P, Valgimigli M, Windecker S, Steg P, Hamm C, Juni P, et al.
EuroIntervention
. 2015 Nov;
12(10):1239-1245.
PMID: 26606735
Aims: The GLOBAL LEADERS trial is a superiority study in patients undergoing percutaneous coronary intervention, with a uniform use of Biolimus A9-eluting stents (BES) and bivalirudin. GLOBAL LEADERS was designed...
5.
Sabate M, Brugaletta S, Cequier A, Iniguez A, Serra A, Jimenez-Quevedo P, et al.
Lancet
. 2015 Nov;
387(10016):357-366.
PMID: 26520230
Background: Data for the safety and efficacy of new-generation drug-eluting stents at long-term follow-up, and specifically in patients with ST-segment elevation myocardial infarction, are scarce. In the EXAMINATION trial, we...
6.
Sabate M, Windecker S, Iniguez A, Okkels-Jensen L, Cequier A, Brugaletta S, et al.
Eur Heart J
. 2015 Sep;
37(3):229-40.
PMID: 26405232
Aims: Patients with ST-segment elevation myocardial infarction (STEMI) feature thrombus-rich lesions with large necrotic core, which are usually associated with delayed arterial healing and impaired stent-related outcomes. The use of...
7.
Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, et al.
EuroIntervention
. 2013 May;
9(8):1009-10.
PMID: 23628520
No abstract available.
8.
Farooq V, van Klaveren D, Steyerberg E, Meliga E, Vergouwe Y, Chieffo A, et al.
Lancet
. 2013 Feb;
381(9867):639-50.
PMID: 23439103
Background: The anatomical SYNTAX score is advocated in European and US guidelines as an instrument to help clinicians decide the optimum revascularisation method in patients with complex coronary artery disease....
9.
Farooq V, Serruys P, Garcia-Garcia H, Zhang Y, Bourantas C, Holmes D, et al.
J Am Coll Cardiol
. 2012 Dec;
61(3):282-94.
PMID: 23265332
Objectives: The study sought to evaluate the clinical impact of angiographic complete (CR) and incomplete (ICR) revascularization and its association with the presence of total occlusions (TO), after percutaneous coronary...
10.
Farooq V, Serruys P, Bourantas C, Vranckx P, Diletti R, Garcia H, et al.
Eur Heart J
. 2012 Oct;
33(24):3105-13.
PMID: 23103663
Aims: The aim of this investigation was to determine the incidence and multivariable correlates of long-term (4-year) mortality in patients treated with surgical or percutaneous revascularization in the synergy between...